Commentary on: Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.

Published by on

Related Posts

Medical

Expansion of pharmacy preceptors' cannabidiol knowledge and confidence to ensure patient safety

J Am Pharm Assoc (2003). 2021 Apr 1:S1544-3191(21)00150-3. doi: 10.1016/j.japh.2021.03.021. Online ahead of print. NO ABSTRACT PMID:33863654 | DOI:10.1016/j.japh.2021.03.021 Source: ncbi Partage le savoir

Medical

Cannabidiol converts NFkappaB into a tumor suppressor in glioblastoma with defined antioxidative properties

Neuro Oncol. 2021 Apr 17:noab095. doi: 10.1093/neuonc/noab095. Online ahead of print. ABSTRACT BACKGROUND: The transcription factor NFκB drives neoplastic progression of many cancers including primary brain tumors (glioblastoma; GBM). Precise therapeutic modulation of NFκB activity Read more…

Medical

Biopsychosocial Model Social Anxiety and Substance Use Revised

Curr Psychiatry Rep. 2021 Apr 17;23(6):35. doi: 10.1007/s11920-021-01249-5. ABSTRACT PURPOSE OF REVIEW: To review data published in the past 5 years to evaluate the utility of our biopsychosocial model of social anxiety’s relation to substance Read more…

error: Content is protected !!